Laura began her practice as a maker in fine art, completing her MA Sculpture at The Royal College of Art in 2004. The making process has always been an integral part of her work, but came to the fore after an extensive time training, and working, with leatherworkers and bookbinders. For a number of years her practice became a working apprenticeship, learning traditional leatherwork skills and producing bespoke leather interiors. In 2013, having gained a high level of technical knowledge, Laura decided to once more begin her own sculptural work. This new approach, combining accumulated skill, synonymous with craft practice, with a critical and analytical approach, informs her current practice.
Since that time Laura has been a commissioned artist for National Trust collaborations Make the Most and Dangerous Discoveries. In 2014 she won the Perrier-Jouët Art Salon Award, with a solo show at Contemporary Applied Arts, and exhibited with CAA at Collect in 2015. Laura was selected for the Jerwood Makers Open 2017, which is currently touring after an initial exhibition at the Jerwood Space. As one of the finalists in The Woman’s Hour Craft Prize, Laura’s work is currently touring, after the inaugural exhibition at the V&A which ran until February 2018. In 2017 Laura’s work was also shown as part of the exhibition Flora at Ruthin Craft Centre and The New Materiality, a Crafts Council presentation at Tresor Contemporary Craft Fair, Basel. Laura is showing with Joanna Bird at Collect 2018.
Cellular Therapy is the fourth work in a series exploring the cellular morphology of lymphoma (DLBCL); significant because of her partner’s death of the disease in 2015. The first three works [Pathogenesis, Angiogenesis, Regimen] were made as part of the Jerwood Makers Open 2017.
Gallery - click images to enlarge
Cellular Therapy > Enquire
H 60 x W 50 x D 50cm
Cellular Therapy, the final piece in the series, explores a branch of Immunotherapy; a cutting edge therapy in cancer treatment in which cells of the immune system (T-cells) are genetically engineered to generate a protein, which recognises and stimulates the destruction of cancer cells.